Dermapharm Holding SE buy Saftman
Start price
14.09.21
/
50%
€84.50
Target price
14.09.22
-
Performance (%)
-50.67%
End price
15.09.22
€41.68
Summary
This prediction ended on 15.09.22 with a price of €41.68. The BUY prediction by Saftman for Dermapharm Holding SE performed very badly with a performance of -50.67%. Saftman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -2.752% | -2.752% | -1.592% | -4.921% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by Saftman for this prediction
In the thread Dermapharm Holding SE diskutieren
Saftman hat das Wertpapier Dermapharm Holding SE in seinem Wikifolio Trendfolge nach Levy gekauft.
In the thread Trading Dermapharm Holding SE
Die von Saftman gewählte maximale Laufzeit wurde überschritten